Abbott Diagnostics Quality System Violations Require Outside Audit By August
This article was originally published in The Gray Sheet
Executive Summary
Abbott's pending sale of its diagnostics business to GE will not be affected by an FDA warning letter citing quality control problems at its Irving, Texas, plant, the company claims